Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01813747 · ClinicalTrials.gov registry record · NA
Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece
A NA study, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT01813747: Completed NA study, sponsored by Cynosure.
NCT01813747 is a NA study that has completed, run by Cynosure. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01813747, a NA study, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to use the 1440nm Wavelength laser along with the hand piece to provide clinical outcome data for treatment of the mandibular and submandibular areas specifically for skin tightening and laser lipolysis.
Primary Outcome
Photos will be evaluated by the investigator comparing time baseline and 3 month photos using the global aesthetic improvement scale
Interventions
- DEVICE 1440 nm wavelength laser with handpiece (Cynosure)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-08 |
| Phase | NA |
What the finished NCT01813747 record still lists
NCT01813747 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which 1440 nm wavelength laser with handpiece (Cynosure) is the first listed.
NCT01813747 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01813747 about?
NCT01813747 is a clinical study titled "Mandible and Sub-mandible Using the 1440nm Wavelength Laser and Hand Piece". The purpose of this study is to use the 1440nm Wavelength laser along with the hand piece to provide clinical outcome data for treatment of the mandibular and submandibular areas specifically for skin tightening and laser lipolysis.
What is the current status of trial NCT01813747?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2012-08. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01813747?
The interventions under investigation include: 1440 nm wavelength laser with handpiece (Cynosure) (DEVICE).
Who is sponsoring clinical trial NCT01813747?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01813747's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia